New Oral Anticoagulants Use in Renal Disease and Af (noacure-Af) - Where Do We Stand?: an Expert Consensus View Using the Delphi Method
| dc.contributor.author | Arici M. | |
| dc.contributor.author | Ecder T. | |
| dc.contributor.author | Erdinler I. | |
| dc.contributor.author | Ok E. | |
| dc.contributor.author | Özlük Ö.A. | |
| dc.contributor.author | Türk U.Ö. | |
| dc.contributor.author | Alio?lu E. | |
| dc.date.accessioned | 2023-06-16T15:04:30Z | |
| dc.date.available | 2023-06-16T15:04:30Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | [No abstract available] | en_US |
| dc.identifier.doi | 10.5543/TKDA.2021.40652 | |
| dc.identifier.issn | 1016-5169 | |
| dc.identifier.issn | 1308-4488 | |
| dc.identifier.scopus | 2-s2.0-85110345161 | |
| dc.identifier.uri | https://doi.org/10.5543/TKDA.2021.40652 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/486144 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/3828 | |
| dc.language.iso | tr | en_US |
| dc.publisher | Turkish Society of Cardiology | en_US |
| dc.relation.ispartof | Turk Kardiyoloji Dernegi Arsivi | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | anticoagulant agent | en_US |
| dc.subject | antifibrinolytic agent | en_US |
| dc.subject | antithrombin | en_US |
| dc.subject | warfarin | en_US |
| dc.subject | atrial fibrillation | en_US |
| dc.subject | consensus | en_US |
| dc.subject | Delphi study | en_US |
| dc.subject | human | en_US |
| dc.subject | kidney disease | en_US |
| dc.subject | Review | en_US |
| dc.subject | scientific literature | en_US |
| dc.subject | adverse event | en_US |
| dc.subject | atrial fibrillation | en_US |
| dc.subject | cerebrovascular accident | en_US |
| dc.subject | chronic kidney failure | en_US |
| dc.subject | complication | en_US |
| dc.subject | diabetic complication | en_US |
| dc.subject | heart failure | en_US |
| dc.subject | hemodialysis | en_US |
| dc.subject | hypertension | en_US |
| dc.subject | oral drug administration | en_US |
| dc.subject | risk factor | en_US |
| dc.subject | vascular disease | en_US |
| dc.subject | Administration, Oral | en_US |
| dc.subject | Antifibrinolytic Agents | en_US |
| dc.subject | Antithrombins | en_US |
| dc.subject | Atrial Fibrillation | en_US |
| dc.subject | Consensus | en_US |
| dc.subject | Delphi Technique | en_US |
| dc.subject | Diabetes Complications | en_US |
| dc.subject | Heart Failure | en_US |
| dc.subject | Humans | en_US |
| dc.subject | Hypertension | en_US |
| dc.subject | Kidney Failure, Chronic | en_US |
| dc.subject | Renal Dialysis | en_US |
| dc.subject | Renal Insufficiency, Chronic | en_US |
| dc.subject | Risk Factors | en_US |
| dc.subject | Stroke | en_US |
| dc.subject | Vascular Diseases | en_US |
| dc.subject | Warfarin | en_US |
| dc.title | New Oral Anticoagulants Use in Renal Disease and Af (noacure-Af) - Where Do We Stand?: an Expert Consensus View Using the Delphi Method | en_US |
| dc.title.alternative | Böbrek Hastali?i Olan Af Olgularinda Non-vitamin K Antagonisti Oral Antikoagülanlarin Kullanimi (noacure-af) - Neredeyiz?: Delphi Yöntemi Kullanan Bir Uzman Uzlaşi Raporu | en_US |
| dc.type | Review | en_US |
| dspace.entity.type | Publication | |
| gdc.author.scopusid | 36338307600 | |
| gdc.author.scopusid | 6602320842 | |
| gdc.author.scopusid | 7005643278 | |
| gdc.author.scopusid | 55751604100 | |
| gdc.author.scopusid | 12774004400 | |
| gdc.author.scopusid | 8868351600 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::review | |
| gdc.collaboration.industrial | false | |
| gdc.description.departmenttemp | Arici, M., Hacettepe Üniversitesi, Tip Fakültesi, Nefroloji Anabilim Dali, Ankara, Turkey; Ecder, T., Demiro?lu Bilim Üniversitesi, Tip Fakültesi, Nefroloji Anabilim Dali, Istanbul, Turkey; Erdinler, I., Memorial Ataşehir Hastanesi, Kardiyoloji Bölümü, Istanbul, Turkey; Ok, E., Ege Üniversitesi Tip Fakültesi, Nefroloji Anabilim Dali, Izmir, Turkey; Özlük, Ö.A., Yüksek Ihtisas E?itim ve Araştirma Hastanesi, Kardiyoloji Anabilim Dali, Bursa, Turkey; Türk, U.Ö., Izmir Ekonomi Üniversitesi, Tip Fakültesi, Kardiyoloji Anabilim Dali, Izmir, Turkey; Alio?lu, E., Izmir Ekonomi Üniversitesi, Tip Fakültesi, Kardiyoloji Anabilim Dali, Izmir, Turkey | en_US |
| gdc.description.endpage | 352 | en_US |
| gdc.description.issue | 5 | en_US |
| gdc.description.publicationcategory | Diğer | en_US |
| gdc.description.scopusquality | Q4 | |
| gdc.description.startpage | 345 | en_US |
| gdc.description.volume | 49 | en_US |
| gdc.description.wosquality | Q4 | |
| gdc.identifier.openalex | W3184781813 | |
| gdc.identifier.pmid | 34308867 | |
| gdc.identifier.trdizinid | 486144 | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.accesstype | GOLD | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.4895952E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Nonvalvular Atrial-Fibrillation | |
| gdc.oaire.keywords | Consensus | |
| gdc.oaire.keywords | Delphi Technique | |
| gdc.oaire.keywords | Administration, Oral | |
| gdc.oaire.keywords | Outcomes | |
| gdc.oaire.keywords | Antithrombins | |
| gdc.oaire.keywords | Diabetes Complications | |
| gdc.oaire.keywords | Chronic Kidney-Disease | |
| gdc.oaire.keywords | Rivaroxaban | |
| gdc.oaire.keywords | Renal Dialysis | |
| gdc.oaire.keywords | Risk Factors | |
| gdc.oaire.keywords | Atrial Fibrillation | |
| gdc.oaire.keywords | Diseases of the circulatory (Cardiovascular) system | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Hemodialysis-Patients | |
| gdc.oaire.keywords | Vascular Diseases | |
| gdc.oaire.keywords | Renal Insufficiency, Chronic | |
| gdc.oaire.keywords | Internal medicine | |
| gdc.oaire.keywords | Heart Failure | |
| gdc.oaire.keywords | R | |
| gdc.oaire.keywords | Risk Scores | |
| gdc.oaire.keywords | RC31-1245 | |
| gdc.oaire.keywords | Antifibrinolytic Agents | |
| gdc.oaire.keywords | Stroke | |
| gdc.oaire.keywords | RC666-701 | |
| gdc.oaire.keywords | Hypertension | |
| gdc.oaire.keywords | Medicine | |
| gdc.oaire.keywords | Kidney Failure, Chronic | |
| gdc.oaire.keywords | Warfarin | |
| gdc.oaire.keywords | Dialysis | |
| gdc.oaire.popularity | 1.5483943E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.16 | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 11 | |
| gdc.plumx.scopuscites | 1 | |
| gdc.scopus.citedcount | 1 | |
| gdc.virtual.author | Türk Uğur Önsel | |
| gdc.virtual.author | Alioğlu, Emin | |
| relation.isAuthorOfPublication | 8d390c57-c78e-484a-a346-1b5a22b4d6f1 | |
| relation.isAuthorOfPublication | b87e91a3-6083-43b2-ab3a-fa16f30bee18 | |
| relation.isAuthorOfPublication.latestForDiscovery | 8d390c57-c78e-484a-a346-1b5a22b4d6f1 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication | 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd | |
| relation.isOrgUnitOfPublication | fbc53f3e-d1d3-4168-afd8-e42cd20bddd9 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 |
Files
Original bundle
1 - 1 of 1